Clinical Trial Update: "Extended" (Alternate Day) Antipsychotic Dosing [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating extended (alternate-day) dosing of an antipsychotic for schizophrenia; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Schizophrenia and Related Disorders, Drug Administration Schedule | Phase 4 | Status: RECRUITING